Drug Type Oncolytic bacteria |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma recurrent | Preclinical | CH | 01 Oct 2024 | |
Ovarian Cancer | Preclinical | FI | - | |
Peritoneal Neoplasms | Preclinical | FI | - | |
Bladder Cancer | Discovery | FI | 23 Sep 2024 |